checkAd

     146  0 Kommentare Magenta Therapeutics Launches Proposed Public Offering - Seite 3


    Business Wire (engl.)
    0 Follower
    Autor folgen
    Seite 3 von 3

    Magenta Therapeutics Launches Proposed Public Offering - Seite 3 Magenta Therapeutics, Inc. (Nasdaq: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of stem cell transplant to more patients, announced that it has commenced an underwritten public offering of $60 …